Evidence map›Paper›PMID 29250188›Full record

ArticleOncology letters2017

Low miR-210 and

Yanyan Mei, Zhigang Li, Yi Zhang, Weiling Zhang, Huimin Hu, Pinwei Zhang, Minyuan Wu, Dongsheng Huang

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. MiRNA Dysregulation in Childhood Hematological Cancer.International journal of molecular sciences · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yanyan MeiDepartment of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing 100176, P.R. China.
Zhigang LiKey Laboratory of Major Diseases in Children, Ministry of Education, Department of Hematology, Beijing Children's Hospital, Capital Medical University, Beijing 100045, P.R. China.
Yi ZhangDepartment of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing 100176, P.R. China.
Weiling ZhangDepartment of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing 100176, P.R. China.
Huimin HuDepartment of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing 100176, P.R. China.
Pinwei ZhangDepartment of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing 100176, P.R. China.
Minyuan WuKey Laboratory of Major Diseases in Children, Ministry of Education, Department of Hematology, Beijing Children's Hospital, Capital Medical University, Beijing 100045, P.R. China.
Dongsheng HuangDepartment of Pediatrics, Beijing Tongren Hospital, Capital Medical University, Beijing 100176, P.R. China.
Beijing Tongren Hospital · CNCapital Medical University · CNBeijing Children’s Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prognostic significance of microRNA (miR)-210 and the caspase 8-associated protein 2 (

Indexed as

caspase 8-associated protein 2childhood acute lymphoblastic leukemiamicroRNA-210minimal residual diseaserelapse

Identifiers

PMID29250188
PMCPMC5730016
OpenAlexW2766187684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.